TY - JOUR AU - Fong Donald, S. AU - Lloyd, A. AU - Gardner Thomas, W. AU - King George, L. AU - George, B. PY - 2004 DA - 2004// TI - Retinopathy in diabetes JO - Diabetes Care VL - 27 UR - https://doi.org/10.2337/diacare.27.2007.S84 DO - 10.2337/diacare.27.2007.S84 ID - Fong Donald2004 ER - TY - JOUR AU - Sarah, W. AU - Gojka, R. AU - Anders, G. AU - Richard, S. AU - Hilary, K. PY - 2004 DA - 2004// TI - Global. prevalence of diabetes: estimates for the year 2000 and projections for 2030 JO - Diabetes Care VL - 27 UR - https://doi.org/10.2337/diacare.27.5.1047 DO - 10.2337/diacare.27.5.1047 ID - Sarah2004 ER - TY - JOUR AU - Adamis, A. P. PY - 2002 DA - 2002// TI - Is diabetic retinopathy an inflammatory disease? JO - Br J Ophthalmol VL - 86 UR - https://doi.org/10.1136/bjo.86.4.363 DO - 10.1136/bjo.86.4.363 ID - Adamis2002 ER - TY - JOUR AU - Joussen, A. M. AU - Murata, T. AU - Tsujikawa, A. AU - Kirchhof, B. AU - Bursell, S. E. PY - 2001 DA - 2001// TI - Leukocyte-mediated endothelial cell injury and death in the diabetic retina JO - Am. J. Pathol VL - 158 UR - https://doi.org/10.1016/S0002-9440(10)63952-1 DO - 10.1016/S0002-9440(10)63952-1 ID - Joussen2001 ER - TY - JOUR AU - Joussen Antonia, M. AU - Vassiliki, P. AU - Nicholas, M. AU - Bernd, K. AU - Kan, K. PY - 2002 DA - 2002// TI - Nonsteroidal anti-inflammatory drugs prevent early diabetic. retinopathy via TNF-alpha suppression JO - FASEB J VL - 16 UR - https://doi.org/10.1096/fj.01-0707fje DO - 10.1096/fj.01-0707fje ID - Joussen Antonia2002 ER - TY - JOUR AU - Abu, E. -. A. A. M. AU - Imtiaz, N. M. AU - Dustan, K. AU - Karel, G. AU - Shamsul, O. M. PY - 2011 DA - 2011// TI - Highmobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy JO - Mol Vis VL - 17 ID - Abu2011 ER - TY - JOUR AU - Ghulam, M. AU - Mairaj, S. M. AU - Amira, O. AU - Mohamed, A. -. S. AU - Abu El-Asrar Ahmed, M. PY - 2013 DA - 2013// TI - High-mobility group box-1 protein activates inflammatory signaling pathway components and disrupts retinal vascular-barrier in the diabetic retina JO - Exp Eye Res VL - 107 UR - https://doi.org/10.1016/j.exer.2012.12.009 DO - 10.1016/j.exer.2012.12.009 ID - Ghulam2013 ER - TY - JOUR AU - Cohen, D. J. AU - Loertscher, R. AU - Rubin, M. F. AU - Tilney, N. L. AU - Carpenter, C. B. PY - 1984 DA - 1984// TI - Cyclosporine: a new immunosuppressive agent for organ transplantation JO - Ann Intern Med VL - 101 UR - https://doi.org/10.7326/0003-4819-101-5-667 DO - 10.7326/0003-4819-101-5-667 ID - Cohen1984 ER - TY - JOUR AU - Hatemi, G. AU - Seyahi, E. AU - Fresko, I. AU - Hamuryudan, V. PY - 2012 DA - 2012// TI - Behcet's syndrome: a critical. digest of the recent literature JO - Clin Exp Rheumatol. VL - 30 ID - Hatemi2012 ER - TY - JOUR AU - González-López Julio, J. AU - Jesús, L. -. A. AU - Rafael, M. L. AU - Roberto, F. B. AU - Gema, R. F. PY - 2012 DA - 2012// TI - Topical cyclosporine for atopic. keratoconjunctivitis JO - Cochrane Database Syst Rev VL - 9 ID - González-López Julio2012 ER - TY - STD TI - Xin Z, Jin C, Ming-cai Q, De-qiang L, Peng Z, et al. The effects of. cyclosporine-A on immunoglobulins deposition in retina of streptozotocin-induced diabetic rats. Zhonghua Nei Ke Za Zhi. 2008;47(2):125–8. ID - ref11 ER - TY - JOUR AU - Carmo, A. AU - Cunha-Vaz, J. G. AU - Carvalho, A. P. AU - Lopes, M. C. PY - 2000 DA - 2000// TI - Effect of cyclosporin-A on the blood--retinal barrier permeability in streptozotocin-induced diabetes JO - Mediat Inflamm VL - 9 UR - https://doi.org/10.1080/09629350020025764 DO - 10.1080/09629350020025764 ID - Carmo2000 ER - TY - JOUR AU - Yuan-juan, Z. AU - Shen, Q. AU - Xue-dong, Z. AU - Bo, L. AU - Yan-hong, F. PY - 2012 DA - 2012// TI - The protective effects on the function and structure of retinae in diabetic rats by. intravitreal injection of cyclosporin A JO - Zhonghua Yan Ke Za Zhi VL - 48 ID - Yuan-juan2012 ER - TY - JOUR AU - Srinivasan, K. AU - Viswanad, B. AU - Lydia, A. AU - Kaul, C. L. AU - Ramarao, P. PY - 2005 DA - 2005// TI - Combination of. high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening JO - Pharmacol Res VL - 52 UR - https://doi.org/10.1016/j.phrs.2005.05.004 DO - 10.1016/j.phrs.2005.05.004 ID - Srinivasan2005 ER - TY - JOUR AU - Joussen Antonia, M. AU - Vassiliki, P. AU - Ly, L. M. AU - Kan, K. AU - Christina, E. PY - 2004 DA - 2004// TI - A central role for inflammation in the pathogenesis of diabetic. retinopathy JO - FASEB J VL - 18 UR - https://doi.org/10.1096/fj.03-1476fje DO - 10.1096/fj.03-1476fje ID - Joussen Antonia2004 ER - TY - JOUR AU - Tang, J. AU - Kern, T. S. PY - 2011 DA - 2011// TI - Inflammation in diabetic retinopathy JO - Prog Retin Eye Res. VL - 30 UR - https://doi.org/10.1016/j.preteyeres.2011.05.002 DO - 10.1016/j.preteyeres.2011.05.002 ID - Tang2011 ER - TY - JOUR AU - Antonetti David, A. AU - Barber Alistair, J. AU - Bronson Sarah, K. AU - Freeman Willard, M. AU - Gardner Thomas, W. PY - 2006 DA - 2006// TI - Diabetic retinopathy: seeing beyond glucose-induced JO - Microvasc Dis. Diab VL - 55 ID - Antonetti David2006 ER - TY - JOUR AU - Miyamoto, K. AU - Khosrof, S. AU - Bursell, S. E. AU - Rohan, R. AU - Murata, T. AU - Clermont, A. C. PY - 1999 DA - 1999// TI - Prevention of leukostasis and vascular leakage in streptozotocin-induced. diabetic retinopathy via intercellular adhesion molecule-1 inhibition JO - Proc Natl Acad Sci. U.S.A. VL - 96 UR - https://doi.org/10.1073/pnas.96.19.10836 DO - 10.1073/pnas.96.19.10836 ID - Miyamoto1999 ER - TY - JOUR AU - Esser, P. AU - Heimann, K. AU - Wiedemann, P. PY - 1993 DA - 1993// TI - Macrophages in proliferative vitreoretinopathy and proliferative diabetic retinopathy: differentiation of subpopulations JO - Br J Ophthalmol VL - 77 UR - https://doi.org/10.1136/bjo.77.11.731 DO - 10.1136/bjo.77.11.731 ID - Esser1993 ER - TY - JOUR AU - Hatice, C. AU - Ilter, V. AU - Ozcan Altan, A. AU - Abdullah, C. AU - Doran, F. PY - 2005 DA - 2005// TI - Interleukin (IL)-6, interleukin (IL)-8 levels and cellular composition. of the vitreous humor in proliferative diabetic retinopathy, proliferative vitreoretinopathy, and traumatic proliferative vitreoretinopathy JO - Ocul Immunol Inflamm VL - 13 UR - https://doi.org/10.1080/09273940490518900 DO - 10.1080/09273940490518900 ID - Hatice2005 ER - TY - JOUR AU - Gariano, R. F. AU - Gardner, T. W. PY - 2005 DA - 2005// TI - Retinal angiogenesis in development and disease JO - Nat VL - 438 UR - https://doi.org/10.1038/nature04482 DO - 10.1038/nature04482 ID - Gariano2005 ER - TY - JOUR AU - Demircan, N. AU - Safran, B. G. AU - Soylu, M. AU - Ozcan, A. A. AU - Sizmaz, S. PY - 2006 DA - 2006// TI - Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy JO - Eye VL - 20 UR - https://doi.org/10.1038/sj.eye.6702138 DO - 10.1038/sj.eye.6702138 ID - Demircan2006 ER - TY - JOUR AU - Kowluru, R. A. AU - Odenbach, S. PY - 2004 DA - 2004// TI - Role of interleukin-1beta in the pathogenesis of diabetic retinopathy JO - Br J Ophthalmol. VL - 88 UR - https://doi.org/10.1136/bjo.2003.038133 DO - 10.1136/bjo.2003.038133 ID - Kowluru2004 ER - TY - JOUR AU - Yugal, B. AU - Padmaja, K. AU - Tesfahun, D. AU - Amanda, D. P. AU - Sayon, R. PY - 2008 DA - 2008// TI - Diabetes-enhanced tumor necrosis factor-alpha production promotes. apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy JO - Am J Pathol VL - 172 UR - https://doi.org/10.2353/ajpath.2008.071070 DO - 10.2353/ajpath.2008.071070 ID - Yugal2008 ER - TY - JOUR AU - Vincent, J. A. AU - Mohr, S. PY - 2007 DA - 2007// TI - Inhibition of caspase-1/interleukin-1beta signaling prevents. degeneration of retinal capillaries in diabetes and galactosemia JO - Diab VL - 56 UR - https://doi.org/10.2337/db06-0427 DO - 10.2337/db06-0427 ID - Vincent2007 ER - TY - JOUR AU - Crabtree, G. R. AU - Olson, E. N. PY - 2002 DA - 2002// TI - NFAT signaling: choreographing the social lives of cells JO - Cell VL - 109 UR - https://doi.org/10.1016/S0092-8674(02)00699-2 DO - 10.1016/S0092-8674(02)00699-2 ID - Crabtree2002 ER - TY - JOUR AU - Dawson, J. AU - Kurtenbach, U. AU - MacKenzie, A. PY - 1996 DA - 1996// TI - Cyclosporin A inhibits the in vivo production of interleukin-1beta and tumor necrosis factor alpha, but not interleukin-6, by a T-cell-independent mechanism JO - Cytokine VL - 8 UR - https://doi.org/10.1006/cyto.1996.0118 DO - 10.1006/cyto.1996.0118 ID - Dawson1996 ER - TY - JOUR AU - Kunz, D. AU - Walker, G. AU - Eberhardt, W. AU - Nitsch, D. AU - Pfeilschifter, J. PY - 1995 DA - 1995// TI - Interleukin 1 beta-induced expression of nitric oxide synthase in rat renal mesangial cells is suppressed by cyclosporin A JO - Biochem Biophys Res Commun VL - 216 UR - https://doi.org/10.1006/bbrc.1995.2642 DO - 10.1006/bbrc.1995.2642 ID - Kunz1995 ER - TY - JOUR AU - Espevik, T. AU - Figari, I. S. AU - Shalaby, M. R. AU - Lackides, G. A. AU - Lewis, G. D. PY - 1987 DA - 1987// TI - Inhibition of. cytokine production by cyclosporin A and transforming growth factor beta JO - J Exp Med. VL - 166 UR - https://doi.org/10.1084/jem.166.2.571 DO - 10.1084/jem.166.2.571 ID - Espevik1987 ER - TY - JOUR AU - Einck, L. AU - Bustin, M. PY - 1985 DA - 1985// TI - The intracellular distribution and function of the high mobility group chromosomal proteins JO - Exp Cell Res VL - 156 UR - https://doi.org/10.1016/0014-4827(85)90539-7 DO - 10.1016/0014-4827(85)90539-7 ID - Einck1985 ER - TY - JOUR AU - Raucci, A. AU - Palumbo, R. AU - Bianchi, M. E. PY - 2007 DA - 2007// TI - HMGB1: a signal of necrosis JO - Autoimmun VL - 40 UR - https://doi.org/10.1080/08916930701356978 DO - 10.1080/08916930701356978 ID - Raucci2007 ER - TY - JOUR AU - Bożena, G. AU - Anna, B. AU - Jacek, B. AU - Krzysztof, Ł. AU - Herman Zbigniew, S. PY - 2011 DA - 2011// TI - Immunosuppressant cytoprotection correlates with HMGB1 suppression in primary astrocyte cultures exposed to combined oxygen-glucose deprivation JO - Pharmacol Rep VL - 63 UR - https://doi.org/10.1016/S1734-1140(11)70505-9 DO - 10.1016/S1734-1140(11)70505-9 ID - Bożena2011 ER -